Drug Development in Dementia

Drug development in dementia is a critical endeavor aimed at addressing the urgent need for effective treatments. Researchers are focused on developing medications to slow disease progression, manage symptoms, and enhance quality of life for those affected by conditions like Alzheimer's disease. Efforts include targeting underlying disease mechanisms such as amyloid plaques and tau protein tangles, as well as addressing cognitive decline and behavioral changes. Despite challenges, ongoing research holds promise for advancing new therapies to alleviate the burden of dementia.

 

    Related Conference of Drug Development in Dementia

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 24-25, 2027

    38th Conference on Clinical Neuroscience and Neurogenetics

    Geneva, Switzerland

    Drug Development in Dementia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in